Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis

BACKGROUND: Few observational studies have shown a beneficial effect of dipeptidyl peptidase-4 inhibitors (DPP4i) in patients with coronavirus disease 2019 (COVID-19), although results are not consistent. The present systematic review and meta-analysis was undertaken to provide a precise summary of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Rimesh, Banerjee, Mainak, Mukherjee, Soham, Bhogal, Ranjitpal Singh, Kaur, Amanpreet, Bhadada, Sanjay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897812/
https://www.ncbi.nlm.nih.gov/pubmed/33680425
http://dx.doi.org/10.1177/2042018821996482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897812/
https://www.ncbi.nlm.nih.gov/pubmed/33680425
http://dx.doi.org/10.1177/2042018821996482

Ejemplares similares